Saturday 17 October 2026 Export BNGO’s income statement to Excel — free account

Bionano Genomics, Inc.

BNGO Healthcare Medical Instruments & Supplies

Bionano Genomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.5 million, down 7.37% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 67.8%, free cash flow fell 33.9% and total debt fell 1.91%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.25 0.12 −8.76%

Follow BNGO

Alert me

Market cap: $16.1M
P/E: 0.0×
Fwd P/E: −0.6×
Dividend yield: —
F-score: 5/9
Altman Z: −14.26
Beneish M: −3.39
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	5	5	5	5	+8 more TTM periods Free account
ROE Full definition →	(83.56%)	(73.78%)	(66.15%)	(78.22%)
ROA Full definition →	(52.04%)	(44.12%)	(35.13%)	(46.37%)
ROIC Full definition →	(81.68%)	(126.00%)	(113.43%)	(107.08%)
Return on Tangible Assets Full definition →	(115.46%)	(99.40%)	(70.78%)	(91.88%)
Average Days of Receivables Full definition →	52.81	52.49	66.58	57.52
Free Cash Flow per Share Full definition →	(1.77)	(1.76)	(3.00)	(3.50)
Free Cash Flow Full definition →	(20.48)	(19.30)	(16.34)	(18.67)
Other line items
Cash ROIC Full definition →	(45.04%)	(29.42%)	(21.11%)	(21.93%)
Accounts Receivable Turnover Full definition →	7.68	7.68	5.73	5.84
Accounts Payable Turnover Full definition →	2.93	2.62	2.44	2.11
Inventory Turnover Full definition →	2.29	2.05	1.85	1.45
Average Days of Payables Full definition →	105.12	121.24	133.16	140.89
Days of Inventory on Hand Full definition →	119.87	127.11	129.77	165.80
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	40.43%	42.25%	39.90%	40.46%
Selling, General and Administrative Expense of Revenue Full definition →	113.75%	118.75%	123.30%	132.97%
Share Based Compensation of Revenue Full definition →	11.62%	12.59%	15.90%	19.30%
Operating CF/Net income Full definition →	0.64	0.61	0.62	0.48
Depreciation/Fixed assets Full definition →	0.67	0.62	0.59	0.59
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	2.61	2.62	5.24	5.38
Operating CF per Share Full definition →	(1.77)	(1.76)	(3.00)	(3.50)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly